Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Papaya Growth Opportunity I Unit | PPYAU | Nov 25, 2024 | 11.19 | 0.00 |
Par Pacific | PARR | Nov 25, 2024 | 17.63 | +0.17 |
PAR Technology | PAR | Nov 25, 2024 | 78.33 | +1.19 |
Paragon 28 | FNA | Nov 25, 2024 | 9.86 | -1.79 |
Paramount Global A | PARAA | Nov 25, 2024 | 22.40 | -1.19 |
Paramount Global B | PARA | Nov 25, 2024 | 11.12 | +2.21 |
Paramount Gold Nevada | PZG | Nov 25, 2024 | 0.39 | -3.97 |
Paramount Group | PGRE | Nov 25, 2024 | 4.84 | +1.89 |
Paranovus Entertainment Technology A | PAVS | Nov 25, 2024 | 0.99 | +2.30 |
ParaZero Technologies | PRZO | Nov 25, 2024 | 0.63 | +9.14 |
Park Aerospace | PKE | Nov 25, 2024 | 15.38 | +1.79 |
Park Hotels & Resorts | PK | Nov 25, 2024 | 15.50 | +2.99 |
Park National | PRK | Nov 25, 2024 | 196.95 | -1.53 |
Park-Ohio | PKOH | Nov 25, 2024 | 33.13 | +0.27 |
Parke Bancorp | PKBK | Nov 25, 2024 | 23.61 | +0.25 |
Parker-Hannifin | PH | Nov 25, 2024 | 704.42 | -0.35 |
Parsons | PSN | Nov 25, 2024 | 96.73 | -2.34 |
Pasithea Therapeutics | KTTA | Nov 25, 2024 | 3.05 | -1.61 |
Passage Bio | PASG | Nov 25, 2024 | 0.62 | +22.97 |
Pathfinder Bancorp | PBHC | Nov 25, 2024 | 17.82 | -1.00 |
Pathward Financial | CASH | Nov 25, 2024 | 84.29 | +1.68 |
Patria Investments A | PAX | Nov 25, 2024 | 12.58 | +0.80 |
Patria Latin American Opportunity Acquisition A | PLAO | Nov 25, 2024 | 11.63 | 0.00 |
Patrick Industries | PATK | Nov 25, 2024 | 140.49 | +3.72 |
Patriot National Bancorp | PNBK | Nov 25, 2024 | 1.86 | -1.59 |
Patterson Companies | PDCO | Nov 25, 2024 | 21.62 | +5.67 |
Patterson-UTI Energy | PTEN | Nov 25, 2024 | 8.62 | -0.69 |
PAVmed | PAVM | Nov 25, 2024 | 0.89 | -10.99 |
Paychex | PAYX | Nov 25, 2024 | 145.26 | +0.55 |
Paycom Software | PAYC | Nov 25, 2024 | 234.63 | +1.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.